Colorectal tumors co-express COL5A2 and COL11A1 [79], with COL5A2 protein binding to DDR1 and upregulating the WNT/β-catenin and PI3K/mTOR signaling pathways [80]. The gene discussed is COL5A2; the disease is colorectal neoplasm.